SAFIR02_Breast - Efficacy of Genome Analysis as a Therapeutic Decision Tool for Patients With Metastatic Breast Cancer
Clinical trial NCT02299999 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02299999
- Sponsor
- UNICANCER
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-07
- Primary completion
- 2022-12-01
- Enrollment
- 1460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.